FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

407892002: Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2151722010 Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2159476013 Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2151722010 Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2151722010 Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2159476013 Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2159476013 Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment Is a Betamethasone+calcipotriol (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment Is a Product containing calcipotriol (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Betamethasone false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent cutané false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Vitamin D and/or vitamin D derivative false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Calcipotriol (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment Has manufactured dose form forme pharmaceutique pour usage transdermique et/ou cutané false Inferred relationship Existential restriction modifier (core metadata concept)
    Calcipotriol+betamethasone 50micrograms/500micrograms/g ointment Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    Back to Start